Loading…
Loading…
See exactly how CNBS's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for CNBS and 80,000+ other tickers.
CNBS is an actively managed exchange-traded fund designed to offer broad U.S. market access to the cannabis sector. It invests across the diverse landscape of this industry, encompassing companies involved in cannabis cultivation (plants), essential operational support, and various ancillary businesses. The primary aim of CNBS is to generate capital appreciation for its investors.
The Amplify Seymour Cannabis ETF (NYSEARCA:CNBS) sits at the awkward intersection of a thematic sector bet and an income wrapper.
The Amplify Seymour Cannabis ETF (NYSEARCA:CNBS) has rallied sharply in 2026, with shares up 105% over the past year and 9% in just the last week.
Medical marijuana's US reclassification revives cannabis ETFs like WEED, with tax relief and reform hopes fueling sharp gains across the sector.
Federal cannabis policy moved from theory to action this spring, and three ETFs sit closest to the trade.
Cannabis stocks have seen renewed investor interest as federal policy momentum improves. The most important recent development was the placement of FDA-approved marijuana products and state-regulated medical marijuana products from Schedule I to Schedule III under the Controlled Substances Act.